336 related articles for article (PubMed ID: 7868720)
1. Atypical mole syndrome: risk factor for cutaneous malignant melanoma and implications for management.
Slade J; Marghoob AA; Salopek TG; Rigel DS; Kopf AW; Bart RS
J Am Acad Dermatol; 1995 Mar; 32(3):479-94. PubMed ID: 7868720
[TBL] [Abstract][Full Text] [Related]
2. Risk of developing cutaneous malignant melanoma in atypical-mole syndrome: New York University experience and literature review.
Slade J; Salopek TG; Marghoob AA; Kopf AW; Rigel DS
Recent Results Cancer Res; 1995; 139():87-104. PubMed ID: 7597314
[TBL] [Abstract][Full Text] [Related]
3. A questionnaire survey of Midwest dermatologists on the clinical-genetic aspects of patients with multiple atypical nevi.
Fusaro RM; Johnsen LR; Hoden RH; Lynch HT
Nebr Med J; 1993 May; 78(5):132-7. PubMed ID: 8316319
[TBL] [Abstract][Full Text] [Related]
4. [Genetic counseling and DNA testing in patients with increased risks for malignant melanoma].
Itin PH; Fistarol SK
Ther Umsch; 2003 Aug; 60(8):469-72. PubMed ID: 14502854
[TBL] [Abstract][Full Text] [Related]
5. Dysplastic (atypical) nevi: significance and management.
Lober CW
South Med J; 1992 Sep; 85(9):870-7. PubMed ID: 1523445
[TBL] [Abstract][Full Text] [Related]
6. Prospective follow-up for malignant melanoma in patients with atypical-mole (dysplastic-nevus) syndrome.
Tiersten AD; Grin CM; Kopf AW; Gottlieb GJ; Bart RS; Rigel DS; Friedman RJ; Levenstein MJ
J Dermatol Surg Oncol; 1991 Jan; 17(1):44-8. PubMed ID: 1991880
[TBL] [Abstract][Full Text] [Related]
7. The dangers of atypical mole (dysplastic nevus) syndrome. Teaching at-risk patients to protect themselves from melanoma.
Marghoob AA
Postgrad Med; 1999 Jun; 105(7):147-8, 151-2, 154 passim. PubMed ID: 10376056
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi.
Schneider JS; Moore DH; Sagebiel RW
Arch Dermatol; 1994 Aug; 130(8):1002-7. PubMed ID: 8053695
[TBL] [Abstract][Full Text] [Related]
9. The role of atypical mole syndrome and cutaneous naevi in the development of melanoma.
Easton D
Cancer Surv; 1996; 26():237-49. PubMed ID: 8783577
[No Abstract] [Full Text] [Related]
10. The surgeon, genetics, and malignant melanoma.
Lynch HT; Fusaro RM
Arch Surg; 1992 Mar; 127(3):317-20. PubMed ID: 1550479
[No Abstract] [Full Text] [Related]
11. [Increased incidence of multiple melanoma in sporadic and familial dysplastic nevus cell syndrome].
Sigg C; Pelloni F; Schnyder UW
Hautarzt; 1989 Sep; 40(9):548-52. PubMed ID: 2807914
[TBL] [Abstract][Full Text] [Related]
12. How common is the atypical mole syndrome phenotype in apparently sporadic melanoma?
Newton JA; Bataille V; Griffiths K; Squire JM; Sasieni P; Cuzick J; Bishop DT; Swerdlow A
J Am Acad Dermatol; 1993 Dec; 29(6):989-96. PubMed ID: 8245266
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program.
Hansson J; Bergenmar M; Hofer PA; Lundell G; Månsson-Brahme E; Ringborg U; Synnerstad I; Bratel AT; Wennberg AM; Rosdahl I
J Clin Oncol; 2007 Jul; 25(19):2819-24. PubMed ID: 17602087
[TBL] [Abstract][Full Text] [Related]
14. Risk of cutaneous malignant melanoma in patients with 'classic' atypical-mole syndrome. A case-control study.
Marghoob AA; Kopf AW; Rigel DS; Bart RS; Friedman RJ; Yadav S; Abadir M; Sanfilippo L; Silverman MK; Vossaert KA
Arch Dermatol; 1994 Aug; 130(8):993-8. PubMed ID: 8053716
[TBL] [Abstract][Full Text] [Related]
15. The dilemma of the dysplastic nevus.
Rigel DS
Ann Plast Surg; 1992 Jan; 28(1):9-10. PubMed ID: 1642417
[No Abstract] [Full Text] [Related]
16. Dysplastic nevi-dysplastic nevus syndromes: clinical features and genetic aspects.
Weiss J; Garbe C; Büttner P; Jung EG
Recent Results Cancer Res; 1993; 128():101-18. PubMed ID: 8356313
[No Abstract] [Full Text] [Related]
17. Melanoma risk in individuals with clinically atypical nevi.
Kang S; Barnhill RL; Mihm MC; Fitzpatrick TB; Sober AJ
Arch Dermatol; 1994 Aug; 130(8):999-1001. PubMed ID: 8053717
[TBL] [Abstract][Full Text] [Related]
18. Risk of cutaneous melanoma in dysplastic nevus syndrome types A and B.
Kraemer KH; Tucker M; Tarone R; Elder DE; Clark WH
N Engl J Med; 1986 Dec; 315(25):1615-6. PubMed ID: 3785330
[No Abstract] [Full Text] [Related]
19. Familial cutaneous melanoma.
Lucchina LC; Barnhill RL; Duke DM; Sober AJ
Melanoma Res; 1995 Dec; 5(6):413-8. PubMed ID: 8589615
[TBL] [Abstract][Full Text] [Related]
20. Atypical mole syndrome and dysplastic nevi: identification of populations at risk for developing melanoma - review article.
Silva JH; Sá BC; Avila AL; Landman G; Duprat Neto JP
Clinics (Sao Paulo); 2011; 66(3):493-9. PubMed ID: 21552679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]